` 226590 (MDevice Co Ltd) vs KOSPI 200 Comparison - Alpha Spread

M
226590
vs
K
KOSPI 200

Over the past 12 months, MDevice Co Ltd has underperformed KOSPI 200, delivering a return of -16% compared to KOSPI 200's +116% growth.

Stocks Performance
226590 vs KOSPI 200

Loading...
226590
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
226590 vs KOSPI 200

Loading...
226590
KOSPI 200
Difference
www.alphaspread.com

Performance By Year
226590 vs KOSPI 200

Loading...
226590
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
MDevice Co Ltd vs Peers

KOSPI 200
226590
NVDA
2330
AVGO
MU
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

MDevice Co Ltd
Glance View

Market Cap
161B KRW
Industry
Semiconductors

MDevice Co Ltd develops, manufactures, and sells medical devices for hospitals and clinics. Its products are the tools and disposable items used by doctors and nurses for treatment and surgery, rather than consumer health products people buy for home use. The company makes money by selling these devices to healthcare providers and distributors, and in some cases by supplying products to other companies that market them under their own brands. That means its revenue comes from equipment and consumables that medical customers need to keep buying and replacing. What makes this business different is that it sits inside a tightly regulated part of healthcare where product quality, reliability, and clinical use matter a lot. MDevice is not a hospital or a drug maker; it is a medical hardware supplier that turns engineering and manufacturing know-how into products used directly in patient care.

Intrinsic Value
₩24 233.53
Undervaluation 38%
Intrinsic Value
Price ₩15 020
M
Back to Top